Assessment and characteristics of chronic kidney disease in France;Estimation et caractérisation de l'insuffisance rénale chronique en France

Annales de Cardiologie et d'Angeiologie

Volumn 61, Issue 4, 2012, Pages 239-244

  Bongard, V ^a   Dallongeville, J ^b   Arveiler, D ^c   Ruidavets, J B ^a   Cottel, D ^b   Wagner, A ^c   Ferrieres J ^d  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d CHU RANGUEIL   (France)

Author keywords

Chronic kidney disease; Prevalence; Representative survey; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DYSLIPIDEMIA; FRANCE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; HYPERTENSION; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; FRANCE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84866449972     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2012.03.003     Document Type: Article

References (18)

1. Stengel B. L'insuffisance rénale chronique: une épidémie?. Presse Med 2011, 40(11):1020-1027.
2. Wanner C., Krane V., März W., Olschewski M., Mann J.F., Ruf G., et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005, 353(3):238-248.
3. Fellström B.C., Jardine A.G., Schmieder R.E., Holdaas H., Bannister K., Beutler J., et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009, 360(14):1395-1407.
4. Baigent C., Landray M.J., Reith C., Emberson J., Wheeler D.C., Tomson C., et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet 2011, 377(9784):2181-2192.
5. Reiner Z., Catapano A.L., De Backer G., Graham I., Taskinen M.R., Wiklund O., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS). Eur Heart J 2011, 32(14):1769-1818.
6. Stengel B., Metzger M., Froissart M., Rainfray M., Berr C., Tzourio C., et al. Epidemiology and prognostic significance of chronic kidney disease in the elderly: the three-city prospective cohort study. Nephrol Dial Transplant 2011, 26(10):3286-3295.
7. Stengel B., Jaussent I., Guiserix J., Bourgeon B., Papoz L., Favier F. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion diabetes (REDIA) study. Diabetes Metab 2007, 33(6):444-452.
8. Ferrières J., Bongard V., Dallongeville J., Arveiler D., Cottel D., Haas B., et al. Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007. Arch Cardiovasc Dis 2009, 102(4):293-301.
9. Tilloy E., Cottel D., Ruidavets J.B., Arveiler D., Ducimetière P., Bongard V., et al. Characteristics of current smokers, former smokers, and second-hand exposure and evolution between 1985 and 2007. Eur J Cardiovasc Prev Rehabil 2010, 17(6):730-736.
10. Wagner A., Sadoun A., Dallongeville J., Ferrières J., Amouyel P., Ruidavets J.B., et al. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens 2011, 29(1):43-50.
11. Wyndels K., Dallongeville J., Simon C., Bongard V., Wagner A., Ruidavets J.B., et al. Regional factors interact with educational and income tax levels to influence food intake in France. Eur J Clin Nutr 2011, 65(9):1067-1175.
12. Pigeyre M., Dauchet L., Simon C., Bongard V., Bingham A., Arveiler D., et al. Effects of occupational and educational changes on obesity trends in France: the results of the MONICA France survey 1986-2006. Prev Med 2011, 52(5):305-309.
13. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factors categories. Circulation 1998, 97:1837-1847.
14. Haute Autorité en santé. http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/synthese_efficacite_et_efficience_des_hypolipemiants_-une_analyse_centree_sur_les_statines.pdf.
15. Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008, 8:117.
16. Zhang Q.L., Koenig W., Raum E., Stegmaier C., Brenner H., Rothenbacher D. Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med 2009, 48(2):122-127.
17. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., et al. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298(17):2038-2047.
18. Gifford F.J., Methven S., Boag D.E., Spalding E.M., Macgregor M.S. Chronic kidney disease prevalence and secular trends in a UK population: the impact of MDRD and CKD-EPI formulae. QJM 2011, 104(12):1045-1053.